Inflammation and tumor microenvironment
- PMID: 38448384
- PMCID: PMC10930746
- DOI: 10.11817/j.issn.1672-7347.2023.230231
Inflammation and tumor microenvironment
Abstract
There is a connection between inflammation and cancer. Inflammation is one of the hallmarks of cancer, affecting tumor progression, transition to a malignant phenotype, and the efficacy of tumor chemotherapy. The tumor microenvironment impacts the biological characteristics of tumors through various specific factors and signaling mechanisms. The interaction between inflammation and the tumor microenvironment involves inflammation affecting the tumor microenvironment by inducing immune suppression, while acute inflammation promotes tumor suppression by producing anti-tumor immune responses. This review elaborates on how inflammation affects the tumor microenvironment and thus affects the progression and treatment of tumors, starting from the components of the tumor microenvironment, inflammasomes, cytokines, non-coding RNAs, and other aspects. Inflammatory factors play an important role in regulating inflammatory responses and immune reactions, and they also affect the development of tumors through various pathways in the tumor microenvironment. In addition, non-coding RNAs play an important role in the tumor microenvironment, regulating tumors and inflammation. They are involved in regulating the occurrence, development of tumors, the process of inflammation, as well as regulating inflammation-induced cancer or tumor-related inflammation, and the interaction between the tumor microenvironment, inflammatory factors, and immune cells. Therefore, gaining a deeper understanding of the interaction between inflammation and the tumor microenvironment and its connection to the occurrence and development of cancer can provide a theoretical basis for combating tumors and finding new therapeutic strategies.
炎症与肿瘤之间存在联系。炎症是肿瘤的标志之一,影响肿瘤的进展、向恶性表型的转变以及肿瘤化学治疗药物的疗效,肿瘤微环境通过多种特定因素和信号机制影响肿瘤的生物学特性。炎症与肿瘤微环境之间相互作用,炎症通过诱导免疫抑制来影响肿瘤微环境,急性炎症通过产生抗肿瘤免疫反应来抑制肿瘤。本综述从肿瘤微环境的组分、炎症小体、细胞因子和非编码RNA等方面出发,阐述炎症如何通过影响肿瘤微环境,从而影响肿瘤的进展及治疗。炎症因子在调节炎症反应和免疫应答发挥重要的作用,同时它在肿瘤微环境中通过多种途径影响肿瘤的发展,它可以通过抑制免疫细胞的活性,使肿瘤逃避免疫监视,从而促进肿瘤细胞的增殖和转移。炎症也会引起氧化应激,生成活性氧和活性氮等氧化剂,这些氧化剂会损害核酸、蛋白质和脂质,诱导基因的突变和肿瘤转化。此外,非编码RNA在肿瘤微环境中扮演重要角色,对肿瘤和炎症起调控作用。它们通过多种途径参与调控肿瘤的发生、发展和炎症的过程,也参与调节炎症诱导的肿瘤或肿瘤相关的炎症,以及调节肿瘤微环境、炎症因子和免疫细胞之间的相互作用。因此,更深入地了解炎症与肿瘤微环境之间的相互作用与肿瘤发生、发展之间的联系,可以为肿瘤的治疗提供理论基础和策略。.
Keywords: cyclic RNA; inflammation; tumor; tumor microenvironment.
Conflict of interest statement
作者声称无任何利益冲突。
Similar articles
-
Long non-coding RNAs and cancer mechanisms: Immune cells and inflammatory cytokines in the tumor microenvironment.Med Oncol. 2022 May 17;39(7):108. doi: 10.1007/s12032-022-01680-5. Med Oncol. 2022. PMID: 35578054 Review.
-
The fundamental role of mechanical properties in the progression of cancer disease and inflammation.Rep Prog Phys. 2014 Jul;77(7):076602. doi: 10.1088/0034-4885/77/7/076602. Epub 2014 Jul 9. Rep Prog Phys. 2014. PMID: 25006689 Review.
-
Inflammasomes: Emerging Central Players in Cancer Immunology and Immunotherapy.Front Immunol. 2018 Dec 20;9:3028. doi: 10.3389/fimmu.2018.03028. eCollection 2018. Front Immunol. 2018. PMID: 30631327 Free PMC article. Review.
-
NLRP3 Inflammasome: A Possible Link Between Obesity-Associated Low-Grade Chronic Inflammation and Colorectal Cancer Development.Front Immunol. 2018 Dec 11;9:2918. doi: 10.3389/fimmu.2018.02918. eCollection 2018. Front Immunol. 2018. PMID: 30619282 Free PMC article. Review.
-
Effects of immune cells and cytokines on inflammation and immunosuppression in the tumor microenvironment.Int Immunopharmacol. 2020 Nov;88:106939. doi: 10.1016/j.intimp.2020.106939. Epub 2020 Sep 22. Int Immunopharmacol. 2020. PMID: 33182039 Review.
Cited by
-
NGR-modified nanovesicles target ALKBH5 to inhibit ovarian cancer growth and metastasis.Theranostics. 2025 Jun 9;15(14):6702-6718. doi: 10.7150/thno.107766. eCollection 2025. Theranostics. 2025. PMID: 40585991 Free PMC article.
-
Application of responsive nano-drug carriers in bone tumor chemotherapy.J Bone Oncol. 2025 May 16;52:100689. doi: 10.1016/j.jbo.2025.100689. eCollection 2025 Jun. J Bone Oncol. 2025. PMID: 40497012 Free PMC article. Review.
-
The ovarian cancer-associated microbiome contributes to the tumor's inflammatory microenvironment.Front Cell Infect Microbiol. 2024 Oct 21;14:1440742. doi: 10.3389/fcimb.2024.1440742. eCollection 2024. Front Cell Infect Microbiol. 2024. PMID: 39497925 Free PMC article. Review.
-
Multi-Drug Resistance and Breast Cancer Progression via Toll-Like Receptors (TLRs) Signaling.Cell Biochem Biophys. 2024 Dec;82(4):3015-3030. doi: 10.1007/s12013-024-01418-2. Epub 2024 Aug 7. Cell Biochem Biophys. 2024. PMID: 39110298 Review.
-
The Impact of Inflammation on the Etiopathogenesis of Benign Salivary Gland Tumors: A Scoping Review.Int J Mol Sci. 2024 Nov 22;25(23):12558. doi: 10.3390/ijms252312558. Int J Mol Sci. 2024. PMID: 39684268 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical